Zuora, Inc Spending and interest coverage
- R&D / revenue · 12 months: Value 23.35%; Formula and calculation Research and development expense / revenue. Period ending 2024-10-31..
- Stock-based compensation / revenue · 12 months: Value 20.36%; Formula and calculation Share-based compensation / revenue. Period ending 2024-10-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2024-10-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 23.35% | Research and development expense / revenue. Period ending 2024-10-31. $105.71M ÷ $452.76M × 100 ≈ 23.35% |
| Stock-based compensation / revenue · 12 months | 20.36% | Share-based compensation / revenue. Period ending 2024-10-31. $92.18M ÷ $452.76M × 100 ≈ 20.36% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 105.71M USD | Research and Development Expense |
| Revenue | 452.76M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 92.18M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -42.55M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2024-10-31 | $105.71M | $452.76M | $92.18M | $-42.55M | (m) | 23.35% | 20.36% | (m) | (m) |
| 2024-07-31 | $106.38M | $445.68M | $93.35M | $-39.65M | (m) | 23.87% | 20.95% | (m) | (m) |
| 2024-04-30 | $106.19M | $438.33M | $94.29M | $-48.20M | $23.86M | 24.22% | 21.51% | -2.02× | Reported |
| 2024-01-31 | $108.29M | $431.66M | $101.05M | $-64.41M | $21.48M | 25.09% | 23.41% | -3.00× | Reported |
| 2023-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-04-30 | $105.36M | $405.98M | $98.80M | $-183.98M | $17.74M | 25.95% | 24.34% | -10.37× | Reported |
| 2023-01-31 | $102.56M | $396.09M | $96.40M | $-187.46M | $15.13M | 25.89% | 24.34% | -12.39× | Reported |
| 2022-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-01-31 | $83.22M | $346.74M | $72.07M | $-96.18M | $152.00K | 24.00% | 20.79% | -632.74× | Reported |
| 2021-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-31 | $76.80M | $305.42M | $59.28M | $-73.86M | $334.00K | 25.14% | 19.41% | -221.14× | Reported |
| 2020-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-01-31 | $74.40M | $276.06M | $45.05M | $-85.67M | (m) | 26.95% | 16.32% | (m) | (m) |
| 2019-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-01-31 | $54.42M | $234.99M | $25.36M | $-70.42M | (m) | 23.16% | 10.79% | (m) | (m) |
| 2018-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-01-31 | $38.64M | $171.11M | $8.99M | $-38.08M | (m) | 22.58% | 5.25% | (m) | (m) |
| 2017-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-01-31 | $26.36M | $113.01M | $4.38M | $-39.03M | (m) | 23.32% | 3.88% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.